. 2019 Jun 12;3(2):pkz031. doi: 10.1093/jncics/pkz031

Table 2.

Crude hazard ratio (HR) for death in adolescent and young adult California residents during 2001–2014 compared with 1988–2000

Site	Overall: Crude	Overall: Adjusted	Stage				Sex		Age group, y					Race and ethnicity					Socioeconomic status
Site	Overall: Crude	Overall: Adjusted	Localized	Regional	Distant	Unknown	Male	Female	15–19	20–24	25–29	30–34	35–39	Asian and Pacific Islander	Black	Latino white	Non-Latino white	Other or unknown	High	Mid-high	Middle	Mid-low	Low
Total	0.65^*	0.70^*	0.66^*	0.74^*	0.70^*	0.58^*	0.55^*	0.84^*	0.83^*	0.84^*	0.63^*	0.58^*	0.66^*	0.75^*	0.66^*	0.69^*	0.57^*	0.99	0.58^*	0.59^*	0.64^*	0.69^*	0.72^*
Bone and soft tissue sarcoma	1.10†	1.03	1.11	1.04	0.99	0.90	1.09	1.11	0.91	1.20	1.27†	1.08	1.10	1.27	1.39†	1.02	1.02	3.43†	1.05	1.00	1.25†	1.12	1.06
Brain and CNS: Invasive	0.89^*	0.93^*	0.89^*	1.00	0.99	0.88	0.90^*	0.88^*	0.92	0.90	0.94	0.86^*	0.93	0.94	0.86	0.94	0.83^*	1.34	0.93	0.90^*	0.87	0.87^*	0.86^*
Breast	0.84^*	0.77^*	0.83^*	0.72^*	0.75^*	1.16	0.63	0.84^*	1.80	0.77	0.74^*	0.79^*	0.88^*	0.86^*	0.92	0.81^*	0.82^*	1.09	0.78^*	0.80^*	0.83^*	0.88^*	0.91
Cervix	1.06	0.91^*	0.93	0.89^*	0.91	0.60^*	—	1.06	2.39	1.72†	1.07	1.02	1.02	0.82	1.17	1.01	1.08	2.62†	1.10	0.93	1.05	1.05	1.16†
Colorectal	0.95	0.86^*	0.88	0.90	0.82^*	0.80	0.93	0.98	0.79	0.94	1.11	0.93	0.92	1.07	0.93	1.01	0.88^*	1.38	0.86^*	0.98	0.85^*	0.95	1.07
Kaposi sarcoma	0.30^*	0.26^*	0.22^*	0.37^*	0.34^*	0.36^*	0.29^*	0.75	2.07	0.49^*	0.29^*	0.32^*	0.28^*	0.22^*	0.40^*	0.33^*	0.24^*	0.39^*	0.17^*	0.28^*	0.31^*	0.29^*	0.42^*
Kidney	0.61^*	0.81^*	0.82	1.08	0.83	0.60	0.64^*	0.55^*	0.47	0.76	0.91	0.63^*	0.55^*	1.21	0.81	0.63^*	0.49^*	1.24	0.53^*	0.51^*	0.56^*	0.81	0.59^*
Leukemia: ALL	0.87^*	0.84^*	—	—	0.87^*	—	0.84^*	0.92	0.70^*	0.94	1.10	0.98	0.89	0.81	0.82	0.85^*	0.79^*	2.07	0.83	0.98	0.86	0.88	0.76^*
Leukemia: AML	0.71^*	0.71^*	—	—	0.71^*	—	0.75^*	0.68^*	0.64^*	0.80^*	0.78^*	0.65^*	0.71^*	0.63^*	0.70^*	0.76^*	0.69^*	0.71	0.61^*	0.63^*	0.65^*	0.78^*	0.84^*
Leukemia: CML	0.33^*	0.33^*	—	—	0.33^*	—	0.38^*	0.23^*	0.26^*	0.24^*	0.34^*	0.39^*	0.34^*	0.22^*	0.51^*	0.35^*	0.31^*	0.33	0.30^*	0.40^*	0.26^*	0.28^*	0.41^*
Lip, oral cavity, and pharynx	0.88	0.86^*	0.89	0.79^*	0.79	0.75	0.91	0.88	2.21	2.03	1.06	0.85	0.81^*	0.82	0.46^*	1.01	0.99	0.82	0.93	0.77	1.01	0.97	0.70^*
Lung	0.71^*	0.70^*	0.59^*	0.45^*	0.69^*	0.80	0.71^*	0.73^*	1.00	0.75	0.81	0.70^*	0.78^*	0.97	0.62^*	0.66^*	0.68^*	0.90	0.69^*	0.70^*	0.63^*	0.79^*	0.76^*
Lymphoma: Hodgkin	0.69^*	0.68^*	0.70	0.74^*	0.68^*	0.42^*	0.65^*	0.78^*	0.71^*	0.81	0.64^*	0.54^*	0.87	0.99	0.71^*	0.71^*	0.60^*	1.13	0.72^*	0.62^*	0.65^*	0.85	0.59^*
Lymphoma: Non-Hodgkin	0.35^*	0.38^*	0.20^*	0.38^*	0.43^*	0.39^*	0.32^*	0.57^*	0.53^*	0.46^*	0.36^*	0.31^*	0.36^*	0.47^*	0.41^*	0.41^*	0.29^*	0.39^*	0.27^*	0.26^*	0.33^*	0.39^*	0.48^*
Melanoma	0.78^*	0.75^*	0.63^*	0.65^*	1.00	1.00	0.79^*	0.80^*	0.90^*	0.74^*	0.77^*	0.85^*	0.74^*	0.61	0.44	0.85	0.77^*	0.36	0.77^*	0.71^*	0.83^*	0.74^*	0.90
Ovary: Carcinoma	1.00	1.11	1.16	0.96	1.19†	0.74	—	1.00	1.14	1.55	0.78	0.95	1.05	0.89	1.10	1.00	0.95	1.31	0.98	0.91	1.00	1.21	0.85
Ovary: Germ cell	0.75	0.85	0.81	0.15	0.93	—	—	0.75	0.70	0.42	0.98	0.53	2.10	0.15	1.00	0.90	0.86	—	0.56	0.78	1.11	0.50	0.82
Stomach	0.98	0.92	0.96	0.88	0.92	0.85	1.00	0.96	1.36	0.91	1.06	0.94	0.97	1.04	0.89	1.03	0.81^*	0.84	0.92	0.94	0.88	1.08	1.02
Testis	0.94	0.93	0.87	0.95	1.03	0.94	0.94	—	0.83	1.06	0.92	0.82	0.97	1.04	1.31	0.94	0.74^*	1.16	1.01	0.77	0.98	0.81^*	1.00
Thyroid	0.97	1.00	1.01	0.93	1.48	1.29	1.05	0.95	0.67	1.43	0.77	1.13	0.91	1.42	0.70	0.86	1.04	0.31	0.84	1.01	0.96	0.94	1.06
Uterus	1.10	1.06	1.09	0.90	0.93	2.29	—	1.10	—	4.75	1.15	1.04	1.10	1.37	1.08	1.07	1.04	5.67†	0.89	1.18	1.22	0.87	1.35
Other‡	0.95^*	0.94^*	1.23†	0.97	0.86^*	0.98	0.94^*	0.99	1.06	1.09	1.09	0.94	0.90^*	0.80^*	0.92	0.94	0.96	1.58†	0.90^*	0.98	0.96	0.99	0.91^*

Indicates a statistically significant lower risk for death in 2001–2014 compared to 1988–2000. Risk group 2001–2014, reference group 1988–2000. Adjusted overall hazard ratio = hazard ratio for time period adjusted for stage, sex, age, race and ethnicity, and socioeconomic status. ALL = acute lymphocytic leukemia; AML = acute myeloid leukemia; CML = chronic myeloid leukemia; CNS = central nervous system.

^†

Indicates a statistically significant higher risk for death in 2001–2014 compared with 1988–2000.

No superscript indicates no statistically significant difference in mortality in 2001–2014 compared to 1988–2000.

^‡

Other indicates all noncategorized invasive cancers and benign intracranial tumors. See Supplementary Table 2 (available online) for cancer sites included in other.